CDx
Contact Us

Biospecimen Procurement

Navigate the procurement process with ease by partnering with CellCarta’s sample management team.

Connect with Our Experts
Scientist using a tablet to scan samples.

The Right Samples for Your Study

Finding the right samples for your study can be complex, leading to issues with documentation and regular delays.

To accelerate assay development projects, we can consult our in-house biobank, compliant with the Belgian biobank regulation and containing over 5,000 validated, phenotype-characterized samples.

From to reviewing ethics documentation, CellCarta’s expert sample management team performs biospecimen procurement, ensuring your research can progress without delay.

Temperature-controlled biorepository sample storage warehouse.

Vast Provider Network

We work with many biospecimen providers locally and globally to access fresh samples that are suited to your study’s needs.

Informed consent forms (ICF) are included with all samples and meticulously reviewed by our team before being approved for research use.

Rapid Sample Collection

Collaborating with local hospitals, our Institution Review Board (IRB)-approved sample collection protocols allow for timely human tissue procurement from healthy and disease-state donors.

Our IRB-approved on-site blood collection protocol allows for rapid access to blood samples and study initiation.

Gloved hand holding a labeled blood sample tube during biospecimen procurement.

Why CellCarta

Choose a biospecimen procurement service provider that is reliable, timely, and quality-focused.

Biobank for Fresh Sample Access

Proper Ethics Documentation

Global Logistics Services

On-Site Collection Protocols

Vast Provider Network

A Trusted Sample Logistics Service Provider

CellCarta provides a meticulous range of sample logistic services to support your study at any stage, ensuring samples are always managed with care and quality.

A trusted sample logistics service provider

Frequently Asked Questions

CellCarta's sample management team navigates the full biospecimen procurement process on your behalf, from identifying the right sample providers and managing ethics documentation to ensuring samples match your study's clinical profile. We source from both commercial providers and hospital networks, handling the complexities behind sample logistics for your team. Services are tailored to the scale and requirements of your study.

Through our local and global biospecimen provider network, we source a broad range of sample types including peripheral blood mononuclear cells (PBMCs), bone marrow-derived mast cells (BMMCs), whole blood, plasma, serum, bone marrow aspirate (BMA), and fresh tumor tissue.

Through our partnership with local hospital networks, we can also facilitate rapid access to valuable clinical samples following collection. This includes samples from healthy or disease-state donors (e.g., leukapheresis samples from healthy and HIV donors, fresh lung tumor tissue, etc.).

Biospecimen procurement is available from both healthy donors and disease-state donors across a range of therapeutic areas, including oncology, autoimmune diseases, and infectious diseases. CellCarta maintains IRB-approved sample collection protocols to ensure timely access to clinically relevant specimens. Furthermore, our on-site IRB-approved blood collection protocol from healthy, ICF-consented donors supports rapid study initiation.
Yes. Informed Consent Forms (ICFs) are included with every sample we procure and are meticulously reviewed by our team before samples are approved for research use. We verify that donors are properly consented, de-identified, and match the clinical profile specified for your study. This rigorous ethics review process helps protect your research program from regulatory compliance gaps and downstream delays.